Bebtelovimab in the Real World : Promise and Fulfillment
| Errataetall: |
CommentOn: J Infect Dis. 2022 Nov 11;226(10):1683-1687. - PMID 36124696 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:226 |
|---|---|
| Enthalten in: |
The Journal of infectious diseases - 226(2022), 10 vom: 11. Nov., Seite 1681-1682 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Avery, Robin K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
8YL4SYR6CU |
|---|
| Anmerkungen: |
Date Completed 14.11.2022 Date Revised 15.12.2022 published: Print CommentOn: J Infect Dis. 2022 Nov 11;226(10):1683-1687. - PMID 36124696 Citation Status MEDLINE |
|---|
| doi: |
10.1093/infdis/jiac347 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346411920 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346411920 | ||
| 003 | DE-627 | ||
| 005 | 20231226031403.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiac347 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1154.xml |
| 035 | |a (DE-627)NLM346411920 | ||
| 035 | |a (NLM)36124710 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Avery, Robin K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bebtelovimab in the Real World |b Promise and Fulfillment |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.11.2022 | ||
| 500 | |a Date Revised 15.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Infect Dis. 2022 Nov 11;226(10):1683-1687. - PMID 36124696 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a bebtelovimab | |
| 650 | 4 | |a nirmatrelvir-ritonavir | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 650 | 7 | |a bebtelovimab |2 NLM | |
| 650 | 7 | |a 8YL4SYR6CU |2 NLM | |
| 700 | 1 | |a Dioverti Prono, M Veronica |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 226(2022), 10 vom: 11. Nov., Seite 1681-1682 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
| 773 | 1 | 8 | |g volume:226 |g year:2022 |g number:10 |g day:11 |g month:11 |g pages:1681-1682 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiac347 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 226 |j 2022 |e 10 |b 11 |c 11 |h 1681-1682 | ||